- info@caribiotech.com
- +1 (809) 738 3763
Caribbean Biotech Labs (CBL) is a private Contract Research Organization (CRO) that strives to provide high quality preclinical services to companies in the diagnostic, pharmaceutical and biotechnology industries. With a state-of-the-art cell culture room where we combine our upstream and downstream cell line development process to make sure our customers receive well-qualified non-clinical biologics with reliable product quality. Our GLP Immunology Laboratory is dedicated to developing and validating analytical methods with a unique Quality Management System (QMS) to ensure consistent results.
El equipo científico de CBL está orientado a los resultados, con décadas de experiencia en operaciones de laboratorio CLIA / CAP. Nuestros clientes pueden estar seguros de nuestra capacidad no solo de ofrecer la más alta calidad en nuestros servicios, sino también de nuestra capacidad de comprender y adaptarnos a sus necesidades con gran flexibilidad.
Más que un "tomador de pedidos" nos convertimos en un proveedor de valor y un socio de confianza, al comprometernos con nuestro cliente para satisfacer sus necesidades de investigación y desarrollo.
We foster a networked business model, with increased collaboration and adaptability to our partners' processes, ensuring quality and timely delivery. Our hallmark is to "become an extension of your lab."
Nuestro compromiso con este principio se traduce en la adopción de tecnología avanzada, la capacitación continua de nuestro personal y la implementación de estrictos controles internos. Cada ensayo, análisis o validación se somete a un meticuloso sistema de revisión que asegura la integridad de los datos y la conformidad con las Buenas Prácticas de Laboratorio (BPL).
Paraneoplastic Neurological Syndromes (PNS) are a group of conditions, commonly known as rare diseases, that can affect parts of the central and peripheral nervous system, the neuromuscular junction and the muscle in patients with cancer. However, the neurological disorder develops before the cancer becomes clinically manifest.
Lambert-Eaton myasthenic syndrome (LEMS), subacute cerebellar ataxia and limbic encephalitis (LE) are some of the common manifestations of PNS, which are caused by autoimmune processes triggered by cancer and directed against antigens common to cancer and the nervous system. These syndromes are usually severely disabling.
Because of its high specificity, it has been agreed that the best way to diagnose a neurological disorder as paraneoplastic is to identify one of the well-characterized anti-onconeural protein antibodies in the patient's serum.
Caribbean Biotech Labs (CBL) has decades of experience and structured capabilities in biologics purification. We are experts in preparing all types of biologics and providing full nonclinical drug development services, offering a comprehensive panel of autoimmune disease antigens with a proven track record of quality and sensitivity in radioimmunoprecipitation assays. Maintaining complete consistency of these native antigens shortens both the assay development and validation process.
These autoimmune disease antigens are prepared under Good Laboratory Practice (GLP) regulations.
English 
Spanish